U.S. health body questions AstraZeneca’s COVID-19 vaccine trial data

"Никогда не делает ошибок только тот, кто не пробует ничего нового." Альберт Эйнштейн ZMEY
Время на прочтение: < 1 минуты

By Miyoung Kim and Caroline Copley SINGAPORE (Reuters) – AstraZeneca may have released outdated information on its latest COVID-19 vaccine trial, giving an “incomplete” picture of its efficacy, a leading U.S. health agency said on Tuesday, casting doubt on the shot’s potential U.S. rollout and plunging its developers, once again, into controversy. The surprise public rebuke from federal health officials comes just one day after interim data from the drugmaker showed better-than-expected results from the U.S. trial. That had been seen as a scientific counter to concerns that have dogged the sho…

Read More






Поделиться ссылкой:

Единый Указатель Ресурса: https://zmeinogorsk.ru/u-s-health-body-questions-astrazenecas-covid-19-vaccine-trial-data/

Related posts

Leave a Comment

12 − 1 =